Oppenheimer & Co. Inc. Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Oppenheimer & Co. Inc. increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 85,068 shares of the exchange traded fund’s stock after purchasing an additional 10,168 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in SPDR S&P Biotech ETF were worth $8,405,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of XBI. Hartline Investment Corp increased its stake in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after purchasing an additional 106 shares during the period. First Heartland Consultants Inc. grew its stake in shares of SPDR S&P Biotech ETF by 41.8% in the 3rd quarter. First Heartland Consultants Inc. now owns 7,129 shares of the exchange traded fund’s stock valued at $704,000 after purchasing an additional 2,100 shares during the last quarter. Nations Financial Group Inc. IA ADV increased its holdings in shares of SPDR S&P Biotech ETF by 1.2% in the third quarter. Nations Financial Group Inc. IA ADV now owns 30,363 shares of the exchange traded fund’s stock valued at $3,000,000 after purchasing an additional 372 shares during the period. Venturi Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 11,345.5% during the third quarter. Venturi Wealth Management LLC now owns 1,259 shares of the exchange traded fund’s stock worth $124,000 after purchasing an additional 1,248 shares during the period. Finally, Jaffetilchin Investment Partners LLC grew its position in SPDR S&P Biotech ETF by 3.9% in the 3rd quarter. Jaffetilchin Investment Partners LLC now owns 4,450 shares of the exchange traded fund’s stock valued at $440,000 after buying an additional 166 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $100.01 on Thursday. The company has a market cap of $7.62 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm has a fifty day moving average of $99.07 and a two-hundred day moving average of $95.98. SPDR S&P Biotech ETF has a one year low of $69.32 and a one year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.